We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2024
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Sansure Biotech Demonstrates iPonatic III Portable Molecular Workstation

By LabMedica International staff writers
Posted on 24 May 2023

Sansure Biotech (Hunan, China) is demonstrating its comprehensive range of IVD solutions at EuroMedLab Rome 2023, including the iPonatic III portable molecular workstation.

As a bronze sponsor of the Congress, Sansure is welcoming visitors to its booth where the company’s technicians are showcasing the operations of the iPonatic III portable molecular workstation and presenting its key features and applications. The portable molecular workstation stands out for its ability to deliver extremely accurate test results within 8 to 45 minutes. Equipped with innovative one-tube fast release and rapid PCR amplification technology, it enhances point of care testing (POCT) by optimizing steps such as sample handling, nucleic acid extraction, purification, PCR amplification, and result processing. In addition, the iPonatic III offers a versatile and expandable testing menu, capable of catering to the testing requirements of various pathogens. Its adaptability and portability make it useful in numerous settings, ranging from medical laboratories to emergency rooms. The ultimate objective of this device is to facilitate lab-standard molecular diagnostic services at point-of-care facilities like doctor's offices, clinics, and pharmacies, thereby providing critical support to global healthcare communities.


Image: The iPonatic Ⅲ portable molecular workstation at EuroMedlab 2023 (Photo courtesy of Sansure)
Image: The iPonatic Ⅲ portable molecular workstation at EuroMedlab 2023 (Photo courtesy of Sansure)

Among Sansure’s latest developments in the field of diagnostics being presented at the industry event is the newly-launched Natch 16S nucleic acid extraction system. Natch 16S employs magnetic bead technology and boasts ten different mixing modes. It incorporates a built-in UV lamp and air filtration system, touch control, and a 7-inch touchscreen. With the capacity to extract nucleic acid in 10-60 minutes per batch, the Natch 16S finds applications across numerous fields, including sexually transmitted diseases, women's health, respiratory diseases, gastrointestinal diseases, prenatal and postnatal care, and public health.

Related Links:
Sansure Biotech


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Automated Blood Typing System
IH-500 NEXT
New
Cortisol Rapid Test
Finecare Cortisol Rapid Quantitative Test
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO

Latest EUROMEDLAB 2023 News

DIESSE Diagnostica Unveils CHORUS EVO Immunochemistry Analyzer

LGC Clinical Diagnostics Demonstrates Lab Solutions and Processes to Enhance QC Efficiencies

LumiraDx Demonstrates Fast, High Performance, Portable POC Diagnostic Solution